BeStock  

Danaher DHR

US equityMarket cap rank #119Diagnostics & Research
$230.25 +$3.91 (+1.73%)
Pre-market · Nov 9, 4:00 am ET · After hours $230.25 0.00%
Open$222.96
Prev close$226.34
Day range$222.96 – $230.66
Volume4.06M
Market cap$161.99B
P/E (TTM)37.7
Dividend yield0.66%

Earnings

Average move on report day±4.8%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+7.2%
Worst reaction-11.0%

Stock move on the day after each report

+4.7%2023/Q4+7.2%2024/Q1+5.3%2024/Q2-4.0%2024/Q3-9.7%2024/Q4+3.8%2025/Q1+1.0%2025/Q2+5.9%2025/Q3-4.8%2025/Q4-0.5%2026/Q1-11.0%2026/Q2+4.3%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q321 Oct 2026Pre Market±6.8%+4.29%Within range
2026/Q221 Jul 2026Pre Market±6.4%-10.99%Bigger than priced
2026/Q121 Apr 2026Pre Market±4.8%-0.49%Within range
2025/Q428 Jan 2026Pre Market±4.4%-4.76%Bigger than priced
2025/Q321 Oct 2025Pre Market±6.3%+5.94%Within range
2025/Q222 Jul 2025Pre Market±5.7%+0.98%Within range
2025/Q122 Apr 2025Pre Market±6.9%+3.84%Within range
2024/Q429 Jan 2025Pre Market±4.8%-9.73%Bigger than priced
2024/Q322 Oct 2024Pre Market±5.1%-3.97%Within range
2024/Q223 Jul 2024Pre Market±5.0%+5.30%Bigger than priced
2024/Q123 Apr 2024Pre Market±4.7%+7.21%Bigger than priced
2023/Q430 Jan 2024Pre Market±4.3%+4.71%Bigger than priced
2023/Q324 Oct 2023Pre Market±4.5%-3.53%Within range
2023/Q225 Jul 2023Pre Market±5.0%-0.88%Within range
2023/Q125 Apr 2023Pre Market±3.8%-8.79%Bigger than priced
2022/Q424 Jan 2023Pre Market±4.5%-1.96%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Diagnostics$2.88B 44.0%
  • Life sciences$1.87B 28.5%
  • Biotechnology$1.81B 27.6%

Latest reported quarter: Q3, ended Sep 2026

Revenue$6.55B+8.3% YoY
Operating profit$1.25B+7.9% YoY
Net profit$1.24B+36.0% YoY
Diluted EPS$1.75+37.8% YoY
Free cash flow$1.63B+19.1% YoY
Operating cash flow$1.89B

Revenue, last 8 quarters

$6.5BDec '24$5.7BMar '25$5.9BJun '25$6.1BSep '25$6.8BDec '25$6.0BMar '26$6.3BJun '26$6.6BSep '26

Net profit, last 8 quarters

$1.1BDec '24$954.0MMar '25$555.0MJun '25$908.0MSep '25$1.2BDec '25$1.0BMar '26$870.0MJun '26$1.2BSep '26

Profitability & balance sheet

Gross margin58.6%
Operating margin20.4%
Net margin16.9%
Return on equity8.3%
Return on assets5.0%
Return on invested capital6.1%
Current ratio1.63
Liabilities / assets42.5%
Cash & investments$5.68B
Total debt$26.48B
Net cash (debt)-$20.80B
Free cash flow / sales22.4%

Discussion

No comments yet — be the first to weigh in on DHR.

Sign in to join the discussion.

Scroll to Top